Day: August 10, 2020

TUCSON, Ariz., Aug. 10, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of a Commercialization and Distribution Agreement (Master Agreement) with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (QIAGEN).The 10-year agreement provides a foundation for both companies to combine their technological and commercial strengths with the goal to offer pharmaceutical companies global development, distribution and commercialization capabilities for companion diagnostic (CDx) assays based on HTG EdgeSeq, HTG’s novel RNA platform. The Master Agreement allows HTG to engage directly with biopharma customers for CDx development programs including assay development,...

Additional patients dosed in RDEB, MPS IIIA and MPS IIIB clinical programsGeneral alignment with CHMP on plans for EU registration of ABO-102 for MPS IIIAData from RDEB and MPS III programs presented at recent medical meetingsStrengthened leadership team with appointment of experienced Chief Commercial Officer and two independent Board membersConference call on Tuesday, August 11, 2020 at 8:30 a.m. ETNEW YORK and CLEVELAND, Aug. 10, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced financial results for the second quarter 2020 and recent business progress.“During the past several months, Abeona has delivered on our goals in clinical development, manufacturing, and regulatory affairs toward bringing urgently needed treatments to patients with RDEB...

AUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Asure (NASDAQ: ASUR), a leading provider of cloud-based Human Capital Management (HCM) software solutions, reported results for the second quarter ended June 30, 2020.“We are encouraged by our strong HCM business bookings despite the obvious uncertainty COVD-19 has created for small businesses. Asure continues to make progress on our strategic initiatives, including product innovation and go-to-market investments while accelerating expense reductions after the Workspace business sale. We will never stop providing our customers with the service, technology and support they need to survive and thrive in the crisis,” said Mr. Goepel.Second Quarter 2020 Key HCM HighlightsHCM revenue of $14.1 Million, above consensus of $13.9 MillionNon-GAAP EPS of $0.03, above consensus of $(0.04)HCM bookings...

COVID-19 STARR™ mRNA vaccine candidate, ARCT-021 (LUNAR-COV19) has initiated Phase 1/2 clinical study with Duke-NUS Medical School; Dosing anticipated imminently, initial data expected Q4ARCT-810 (LUNAR-OTC), mRNA therapeutic candidate for ornithine transcarbamylase (OTC) deficiency, Phase 1 healthy volunteer study continues to advance, initial results expected Q4Successfully raised approximately $280 million in gross proceeds through two public equity offerings in 2020 to advance promising clinical stage pipelineInvestor Conference Call at 4:30 p.m. ET TodaySAN DIEGO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within...

NASHVILLE, Tenn., Aug. 10, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2020.  Please click here to review Harrow Health’s Letter to Stockholders for the second quarter 2020.Mark L. Baum, CEO of Harrow Health, commented, “Our team made great progress during a challenging second quarter.  The impact from COVID-19 was substantial for a limited period, but the segments of our economy that are most relevant to our success recovered rapidly and are now at near-normal levels.  The success we’ve seen recently validates the role our formulations play in our customers’ practices.  Thankfully, we are again seeing trends of record-high revenue days into the third quarter as the economy and healthcare providers continue to make a strong comeback.  Also, we recently announced an important...

AUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading provider of professional testing, inspection, engineering, program management and consulting services, announced today that it has entered into a definitive agreement to acquire WesTest LLC (“WesTest”), a key provider of transportation-related materials testing and inspection services, headquartered in Lakewood, Colorado. WesTest has approximately 40 employees, providing a wide range of materials testing, specification development, forensic engineering, geotechnical engineering and construction support services in Colorado.L. Joe Boyer, Atlas’ Chief Executive Officer, said, “We are excited to welcome WesTest to the Atlas family.  The addition of WesTest will expand our testing and engineering capabilities...

SANTA CLARA, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the largest online talent solution, as measured by gross services volume (“GSV”), today announced that President and Chief Executive Officer, Hayden Brown, will participate in a fireside chat at the Canaccord Genuity Global Growth Conference on Wednesday, August 12, 2020 at 11:00 a.m. ET/8:00 a.m. PT.An audiocast of the event will be available in the Events and Presentations section of Upwork’s Investor Relations website at investors.upwork.com. An audio webcast archive will be available following the event for approximately one year at investors.upwork.com. Please contact the financial institution hosting the conference for additional details. During the course of this event, Upwork may disclose material developments affecting its business and/or...

Announced agreement for strategic combination with F-star Therapeutics to advance a pipeline of multiple clinical-stage immuno-oncology programsContinued to advance IV SB 11285 clinical trial to additional monotherapy and combination dosing cohortsAbstracts for IV SB 11285 accepted by major oncology scientific conferences for presentation in Q3 and Q4 2020HOPKINTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of certain cancers and inflammatory diseases, today announced its financial results for the three and six months ended June 30, 2020 and provided an update on recent corporate and clinical development highlights.“We recently announced a proposed strategic combination of Spring Bank with F-star...

— Continued robust treatment response from both high and low doses —— Long-term durability beyond 15 months from single IVT injection with zero rescue injections in Cohort 1 —— Well tolerated across all Cohorts; encouraging early safety data from Cohort 4 —— OPTIC enrollment complete; planning to start pivotal trial in wet AMD mid-2021 —— Company to host conference call and webcast with Key Opinion LeaderDr. Arshad Khanani today at 1:30 pm PT / 4:30 pm ET —REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced positive new interim data from Cohorts 1-4 of the OPTIC Phase 1 clinical trial of ADVM-022 intravitreal (IVT)...

VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper Gold” or the “Company”) (TSXV: PGX)  is pleased to announce that it has entered into a definitive agreement (the “Option Agreement”) with Sabina Gold and Silver Corp. (“Sabina”) (TSX:SBB), whereby Sabina has granted the Company the option to acquire a 100% interest in  the Golden Sidewalk and Skinner gold properties, consisting of approximately 3,000 hectares of mineral claims, leases, and patents, (collectively, the “Properties”) in the Red Lake mining district of Ontario. The Properties are located within the Birch-Uchi greenstone belt approximately 70 km (44 miles) east of Red Lake.“We are excited to begin work in Red Lake district,” said Peter Bernier, President & Chief Executive Officer. “The Golden Sidewalk and Skinner gold properties...